Empower Advisory Group
GILD icon

Empower Advisory Group’s Gilead Sciences GILD Stock Holding History

Empower Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$848K Sell
6,086
-2,786
-31% -$390K ﹤0.01% 255
2025
Q4 		$1.09M Buy
8,872
+3,556
+67% +$432K ﹤0.01% 242
2025
Q3 		$590K Buy
5,316
+294
+6% +$33.4K ﹤0.01% 314
2025
Q2 		$557K Buy
5,022
+47
+0.9% +$5K ﹤0.01% 311
2025
Q1 		$557K Sell
4,975
-1,169
-19% -$121K ﹤0.01% 310
2024
Q4 		$568K Sell
6,144
-1,392
-18% -$125K ﹤0.01% 308
2024
Q3 		$632K Sell
7,536
-3,420
-31% -$261K ﹤0.01% 286
2024
Q2 		$752K Buy
10,956
+3,581
+49% +$239K ﹤0.01% 252
2024
Q1 		$540K Sell
7,375
-2,418
-25% -$186K ﹤0.01% 293
2023
Q4 		$793K Buy
9,793
+2,203
+29% +$171K ﹤0.01% 247
2023
Q3 		$569K Buy
7,590
+91
+1% +$7K ﹤0.01% 282
2023
Q2 		$578K Sell
7,499
-282
-4% -$22.5K ﹤0.01% 287
2023
Q1 		$648K Buy
+7,781
New +$644K ﹤0.01% 275

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Empower Advisory Group's GILD Position: Q1 2026 in Review

Empower Advisory Group reduced its Gilead Sciences (GILD) stake by 31% in Q1 2026, selling an estimated $390K and leaving 6,086 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Empower Advisory Group first reported a position in GILD in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.09M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Empower Advisory Group held 6,086 shares of Gilead Sciences worth $848K as of Q1 2026.
  • Empower Advisory Group sold 2,786 Gilead Sciences shares in Q1 2026, an estimated $390K.
  • Gilead Sciences made up ﹤0.01% of Empower Advisory Group's portfolio in Q1 2026, its #255 holding.
  • Empower Advisory Group first reported a position in Gilead Sciences in Q1 2023 and has held it in 13 quarters since.
  • Empower Advisory Group's Gilead Sciences position peaked at $1.09M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.